Compumedics SEC Filings

Type
Rapport
Dato
Ingen dokumenter tilgjengelig

Compumedics Dokumenter 2026

Denne siden inneholder alle offisielle dokumenter og SEC-innleveringer for Compumedics aksje (CMP.AX, ISIN: AU000000CMP2). Dette inkluderer årsrapporter (Form 10-K), kvartalsrapporter (Form 10-Q) og innsidertransaksjoner (Form 4). For tiden er 0 dokumenter tilgjengelige. Data oppdateres regelmessig for å gi investorer en fullstendig oversikt over Compumedicss regulatoriske innleveringer.

Compumedics Aksjeanalyse

Compumedics Compumedics Ltd., headquartered in Melbourne, Australia, operates in the Health Care sector, specializing in the research, development, manufacture, and distribution of medical equipment. The company employs 135 full-time staff and serves global markets across the Americas, Australia, Asia Pacific, and Europe and the Middle East. Its product portfolio includes sleep diagnostic systems, clinical EEG systems, brain monitoring solutions, ultrasonic blood-flow systems, and technical support services. Key offerings encompass Somfit/Somfit Pro, Grael 4K PSG:EEG, and Compumedics Neuroscan for neurology applications and brain research technologies.